🎉Wellnex Life(AIM: WNX | ASX: WNX) is now dual-listed on the London Stock Exchange, marking a key step in the company’s international expansion strategy 🎉
In this podcast episode, Jack Colreavy, CFA is joined by Zack Bozinovski, Managing Director of Wellnex Life and George Tambassis, Non-Executive Chair of Wellnex Life to discuss the rationale behind the LSE listing and what it means for the company’s next phase of growth.
Key Highlights Include:
1. George has extensive listed corporate governance experience in his capacity as a leading figure in the pharmacy industry.
2. Wellnex Life is now dual-listed on the London Stock Exchange using funds from the capital raise to push forward international growth.
3. Wellnex Life appoints Powermed UK, a leading distributor, to support the expansion of its brand portfolio into the UK market.
4. Haleon brand panadol launched soft gels in the UK using Wellnex Life IP.
5. Wellnex Life has a diversified and defensive portfolio of brands and IP that should perform well in a volatile market.
To learn more about Wellnex Life and stay up to date with investor information, subscribe to the Company's Chairman’s List.
